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Kidney Res Clin Pract 31 (2012) A16–A96A20baseline and at 6, 12, 18 and 24 months following enrollment, in 101
prevalent hemodialysis patients (37% women) with a mean age of
64.6711.5 years. Observation of this cohort was continued over
3 additional years.
Longitudinally, 1O increase in PA over time, controlling for demographic
and clinical parameters, was associated with a delay in longitudinal
elevation of IL-6 (linear estimate: -2.11 (95% CI: -3.47; -0.75) pg/ml/mo;
p¼0.002 for PA X Time interaction). A decrease or increase in PA over
time was associated with inverse linear changes in IL-6 levels (adjusted
r¼-0.305, p¼0.005) and correspondingly with higher or lower death risk.
For each 1O increase in PA, the crude and adjusted mortality hazard ratios
using Cox models with effect of time varying risk were 0.62 (95% CI:
0.54; 0.71) and 0.61 (95% CI: 0.53; 0.71), respectively.
In conclusion, longitudinal changes in PA appeared to be reliable in
detecting changes in nutritional and inﬂammatory parameters over time -
combination that may contribute to understanding of its prognostic bearing.
http://dx.doi.org/10.1016/j.krcp.2012.04.33916
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Dept. of Nephrology,VU University Medical Centre, Amsterdam
The Netherlands Fibroblast growth Factor 23 (FGF23) is independently
associated with cardiovasculair outcome. A reduction of dietary phosphorus
intake in healthy individuals leads to a decrease of FGF23. Data on the potency
of phosphate binders to lower FGF23 in CKD stage 3 are conﬂicting. We treated
18 normophosphatemic CKD stage 3 patients with a ﬁxed dose of sevelamer-
carbonate (Renvelas) 2,4 g powder for suspension, before breakfast and diner.
Patients remained on their usual diet. Laboratory data were collected 2 weeks
prior to baseline, at start of sevelamer, at week 8 following sevelamer treatment
and after a wash-out of 2 weeks. We measured serum phosphorus, PTH, FGF23,
estimated GFR (by the MDRD formula) and 24–h urinary phosphate excretion.
General Estimated Equation was used to evaluate the effect of
phosphorusbinding on 24–h urinary phosphate excretion and on FGF23.patientcharacteristicsn 18
Age(year) 54 (46,1-62,2)
Sex (m/f) 7 / 11
race (% caucasian) 66
eGFR (ml/min/1.73m2) 41.2 7 9.6
FGF23 (U/l) 158 (116-216)
PTH (pmol/l) 7.5(5,4-41,8)
Phosphate (mmol/l) 1.09 7 0.19
Proteinuria (g/24 h) 0,7 (0,2-1,6)Results are as follows; phosphorus binding by sevelamer signiﬁcantly
lowered urinary phosphate excretion, from a median of 26.25 mmol/24 h
to 17.5 mmol/l. Other parameters showed no sgniﬁcant association with
urinary phosphate excretion. The serum phosphate was unchanged during
treatment. Creatinin clearance was signiﬁcantly associated with FGF23
(p0.03). FGF23 did not change signiﬁcant following phosphorus binding
therapy. In conclusion; although 8 weeks sevelamer treatment signiﬁcantly
lowered 24 h urinary phosphate excretion, there was no reduction in
FGF23 levels in this group of CKD stage 3 patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.34017
NUTRITION AND HEMODIALYSIS: THE ASSOCIATION OF DIETITIAN
INTERVENTION TOWARDS ACHIEVING QUALITY PATIENT
DIALYSIS OUTCOMES
archied bunani ali mohammed lehbi
The National Kidney Foundation has recognized nutritional interventions as
building blocks of better dialysis outcomes. This study investigated the
inﬂuence of Dietitian Intervention on mortality, adherence to dialysis
prescriptions, and Quality Patient Dialysis Outcomes. The Subjective Global
Assessment (SGA) tool was used to identify ratings and these ratings wereassociated to the tendency of risk towards mortality using a hazard ratio of 95%
conﬁdence interval in cox regression using SPSS v.19. Results revealed that
respondents whomarked signiﬁcantly as C (1) in the Functional Capacity Items
– Dysfunction (sp¼1.45) showed highest risk (17.5% risk) towards mortality.
This implied that these individuals despite of Dietitian Interventions, mortality
were increased related to co-morbidities. Respondents who had changes on
eating habits in a typical breakfast, lunch, dinner compared from the last 6 months
and those who, during physical examination, had ankle edema showed higher
risk (sp¼1.40) towards mortality at 3.44%. Respondents who showed a B (2) on
metabolic demand (stress) and those with muscle wasting (quadriceps, deltoids)
showed a 2.14% mortality risk (sp¼1.37); lower than those with dysfunction.
Results further indicated that respondents who have higher spKt/V (sp¼1.58)
showed an SGA rating of A (3) and noted to have lowest risks towards
mortality and other co-morbidities.Quality Dialysis
Patient OutcomesHazard Ratio (95% Conﬁdence Interval)SGA Rating Correlation DESCRIPTIONIndicators
Sp Kt/V (o1.2 ¼
41.2)1.58 0.87 STRONGDysfunction 1.22 0.66 STRONG
Changes of Eating
Habits1.36 0.72 STRONGMetabolic demand 1.36 0.78 STRONGIn conclusion, an inﬂuence of Dietitian Intervention was notable to all
patients receiving dialysis treatments. The Clinical Dietitian’s facility in
assisting dialysis patients on the proper diet to be taken associated to
condition will enable the individual to lower mortality risk ratio.
http://dx.doi.org/10.1016/j.krcp.2012.04.34118
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We have previously shown that poorer appetite was a signiﬁcant predictor
of decreased sleep quality (SQ) among maintenance hemodialysis (MHD)
patients. There is a gap in the literature when examining sleep duration (SD)
in MHD patients and the variables that may predict SD. Using data from the
HEMO Study, demographic, case mix, nutrition-related and quality of life
(QOL) variables were explored as predictors of SD in 1805 MHD patients. Self-
reported SD (in hrs) in the last 24 hrs was assessed annually using questions
from the KDQOL instrument. A multinominal logistic regression analysis was
conducted to determine whether SD (short 0–6; medium 7–9; or long 10þ)
was associated with the selected variables and Kt/V and ﬂux randomized
assignments in a longitudinal (repeated measures) model.
At baseline, mean SD was 7.872.4 hrs; 33%, 43% and 24% of subjects were in
the short, medium and long sleep groups, respectively. In univariate analysis,
dietary protein intake, serum albumin, appetite, and QOL measures (mental
component score [MCS] and physical component score [PCS]) were signiﬁcant
predictors of SD. In multivariate analysis, age (P¼0.008), race (White vs. Black)
(P¼0.001), appetite on dialysis days (DD) (P¼0.0001), MCS and PCS
(Po0.0001, respectively) were also signiﬁcant predictors of SD. Younger
patients and those with good appetite on DD were more likely to sleep less,
whereas Blacks and those with higher MCS and PCS were more likely to sleep
more. Of the nutrition variables, higher protein intake and better appetite were
associated with long vs. short SD in univariate analysis. In multivariate analysis,
appetite on DD was the only variable predictive of SD. The odds ratio (95% CI)
of having a good appetite for those in the short SD group compared to the
medium and long SD groups was 0.81 (0.72, 0.92) and 0.86 (0.78, 0.95),
respectively. Further research on SD and appetite and the potential effects of
short sleep on inﬂammation needs to be done in MHD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.342
